Amrita Desai

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

Richard S. Finn, Judy Dering, Dylan Conklin et al. · Breast Cancer Research · 2009 · 1.4K citations · Full text

Medicine, Oncology, Pharmacology +17

Genetic Map of Diploid Wheat, <i>Triticum monococcum</i> L., and Its Comparison With Maps of <i>Hordeum vulgare</i> L.

Jorge Dubcovsky, Ming‐Cheng Luo, Gan‐Yuan Zhong et al. · Genetics · 1996 · 271 citations

Life Sciences, Genetics, Plant Sciences +15

Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006

Karen H. Costenbader, Amrita Desai, Graciela S. Alarcón et al. · Arthritis & Rheumatism · 2011 · 233 citations

Medicine, Internal Medicine, Nephrology +10

Lapatinib, a Dual EGFR and HER2 Kinase Inhibitor, Selectively Inhibits HER2-Amplified Human Gastric Cancer Cells and is Synergistic with Trastuzumab <i>In vitro</i> and <i>In vivo</i>

Zev A. Wainberg, Adrian Anghel, Amrita Desai et al. · Clinical Cancer Research · 2010 · 211 citations

Medicine, Oncology, Pharmacology +16

PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity.

Joshua E. Logan, Nikayeh Mostofizadeh, Amrita Desai et al. · PubMed · 2013 · 102 citations

Medicine, Oncology, Pharmacology +17